Adam Hesse, CEO at Full Spectrum, details the difficulties MedTech companies face when investing in AI and high-tech applications, often struggling to yield significant return on investment. Hesse details four common pitfalls: focusing too much on new technology, guessing and launching without a solid proof of concept, lack of data management, and absence of a clear financial model. He suggests a focused strategy, adequate data support infrastructure, and a clear connection between the AI initiative and the profit & loss account.
Malware Analysis Market Anticipated to Hit USD 28.1 Billion
The malware analysis market is growing due to increased cybersecurity threats and technology adoption. Valued at $6.8bn in 2022, it’s projected to reach $28.1bn by
